Maximillian J Hochmair

26PUBLICATIONS
90CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpidemiological modellingCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Oct 27, 2026
Post-Recurrence Treatment Patterns and Outcomes After Curative-Intent Multimodality Strategy in Patients with Pleural Mesothelioma: A Retrospective Cohort Study.

|Oct 14, 2026
Activity and specificity of KRAS variants-directed Revolution Medicines Company (RMC) compounds for pleural effusion-derived non-small cell lung cancer cell lines.

|May 11, 2026
Structured Expert Elicitation of Long-Term Survival in Non-small Cell Lung Cancer: A Case Study Applying Guidance from NICE Technical Support Document 26.

|Jan 28, 2026
Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study.

Caroline Braschel, Hannah Fabikan, Vania Mikaela Rodriguez

|Nov 20, 2025
Preoperative selpercatinib induces major pathological response in a patient with stage IIIA, RET fusion-positive non-small cell lung cancer: A case report.

Kristina Breitenecker, Hannah Fabikan, Christoph Weinlinger

|Jul 12, 2025
The Efficacy of First-Line Pembrolizumab Monotherapy in Patients with Metastatic NSCLC Aged ≥70 Years with High PD-L1 (TPS ≥ 50%) Expression: A Multicenter Real-World Study.

Filip Marković, Maximilian Hochmair, Nino Müser

Pageof 5

Frequent Collaborators

10 joint publications

Oliver Illini

6 joint publications

Stefan Watzka

3 joint publications

Gerhard Hamilton

2 joint publications

Luka Brcic